Injection burden 12 injections most days Best for Independent dose control Cycle driver Compound-specific phasing BPC-157 Loading 250500 mcg, daily Frequency Daily Maintenance 250 mcg, daily Route SubQ TB-500 Loading 2.05.0 mg, 2x/week Frequency 2x/week (loading), 12x/week (maintenance) Maintenance 2.0 mg, 12x/week Route SubQ Example Weekly Schedule (Loading Phase) Monday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Tuesday BPC-157 500 mcg SubQ Wednesday BPC-157 500 mcg SubQ Thursday BPC-157 500 mcg SubQ + TB-500 2.5 mg SubQ Friday BPC-157 500 mcg SubQ Saturday BPC-157 500 mcg SubQ Sunday BPC-157 500 mcg SubQ Use separate sterile syringes for separate-vial draws
Moreover, it allows for spatiotemporal control of photothermal therapy (PTT), chemotherapy, and chemodynamic therapy (CDT) by tuning the laser power, effectively overcoming resistance barriers seen in conventional therapies and demonstrating potent in vivo antitumor activity
In: Seminars in dialysis
References Guidelines for the management of inflammatory bowel disease in adults
It depends on the protocol format
Injectable GHK-Cu should always come from a 503A or 503B licensed pharmacy with third-party testing